Sandra G. Calman

Sandra G.
Calman is a Member of American Academy of Dermatology.
She served as Chief Medical Officer for Isolagen, Inc. from February 2007 to January 9, 2008.
Prior to joining Isolagen, Dr. Calman held various clinical positions for more than 15 years.
She was Vice President of Medical Affairs and Clinical Research and Chief Medical Officer for Merck KgaA, Dey and Director of Clinical Research for Dow Pharmaceutical Sciences.
Dr. Calman held various senior clinical research positions at Johnson & Johnson and Dow Pharmaceuticals.
She is a Board Certified physician and received her training at the University of Utah School of Medicine.
Dr. Calman has 14 years of experience in clinical research.
She received an undergraduate degree in Family Practice, Pathology and Pharmacology from the University of Utah School of Medicine and holds a BS degree in Biology and Nutrition.
Dr. Calman is an Active Member of the American Academy of Family Practice and the American Academy of Dermatology.